N. M. Bleehen

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.

N. M. Bleehen, E.S. Newlands, Siow Ming Lee et al. · Journal of Clinical Oncology · 1995 · 282 citations

p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus

V. Sundaresan, Peter Ganly, P S Hasleton et al. · Lung Cancer · 1993 · 259 citations

Preinvasive Lesions, Medicine, Pathology +8

The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease

RJ Stephens, DJ Girling, N. M. Bleehen et al. · British Journal of Cancer · 1996 · 189 citations · Full text

M0 Disease, Non-small-cell Lung Cancer, Radiation Therapy +9

The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography

S. Falk, R. Ward, N. M. Bleehen · British Journal of Cancer · 1992 · 130 citations · Full text

Tumour Tissue Oxygenation, Medicine, Computerised P02 Histography +11

A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party.

N. M. Bleehen, D.J. Girling, David Machin et al. · British Journal of Cancer · 1992 · 112 citations

Radiation Medicine, Oncology, Radiation Therapy +7